Clinical trial
Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers
NCT00086567 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00086567 |
|---|---|
| Title | Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers |
| Official title | A Multi-Institutional Study of Proteomic Evaluation of Epithelial Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer Patients in First Clinical Remission: Development of a Protein Fingerprint Profile of Relapse |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Fallopian Tube Cancer, Peritoneal Neoplasms, Epithelial Ovarian Cancer |
| Enrollment | 119 |
| Start date | Dec 12, 2005 |
| First posted | Jul 5, 2004 |
| Last update posted | Jan 8, 2026 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: